Skip to main content

Animations

MJFF Publications

991 - 1000 of 6570 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • Summary Details
    OPEN
    Title: Structure of the second phosphoubiquitin–binding site in parkin
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jbc.2022.102114
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Height and nigral neuron density in Parkinson’s disease
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-022-02775-2
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international setting
    Journal Name: BMJ Open
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1136/bmjopen-2021-049530
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-022-00309-x
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Plcg2M28L Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in Mice
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.886575
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson’s disease-associated GBA gene
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03610-7
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23137086
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac155
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Disruption of mitochondrial complex I induces progressive parkinsonism
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-021-04059-0
    Citation Count: 556
  • Summary Details
    OPEN
    Title: Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xpro.2022.101445
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.